PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1880367
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1880367
The global infection control market is projected to reach USD 77.67 billion by 2030 from USD 57.31 billion in 2025, at a CAGR of 6.3% during the forecast period.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2024-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD billion) |
| Segments | Products & Services and End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries |
The market is expected to experience high growth due to the high global prevalence of healthcare-associated infections (HAIs), a surge in surgeries, advancements in reprocessing technologies, a rising emphasis on the sterilization and disinfection of food, and improvements in sterilization equipment technology. Growing concerns about the safety of reprocessed instruments and the consequences associated with the use of chemical disinfectants will likely restrain market growth.

"The hospitals & clinics segment is expected to hold the largest position during the forecast period"
Based on end user, the market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, the life sciences industry, and other end users. In 2024, hospitals & clinics accounted for the largest share of the market. The hospitals and clinics segment holds the largest share of the infection control market as these facilities operate continuously, manage high patient volumes, and conduct complex medical procedures, all of which heighten the risk of infection transmission. To ensure safe environments for patients and staff, they rely on strict hygiene, disinfection, and sterilization protocols. Moreover, compliance with regulatory requirements and the need to prevent costly infection outbreaks drive significant investment in infection prevention, making hospitals and clinics the leading end users of infection control solutions.
"Cleaning & disinfection products segment accounts for the largest market share in the infection control market"
The infection control market is segmented into sterilization products & services, cleaning & disinfection products, protective barriers, endoscope reprocessing products, and other infection control products, based on treatment. The cleaning & disinfection products segment accounted for the largest share of the market in 2024. Cleaning & disinfection products play a crucial role in infection control as they effectively remove harmful pathogens from surfaces, medical equipment, and environments, thereby reducing the risk of infection transmission. These products are essential for maintaining hygiene standards in hospitals, clinics, laboratories, and other healthcare facilities, thereby protecting patients and healthcare personnel. Their frequent use, wide range of applications, and essential function in interrupting the infection chain make them the most extensively utilized and indispensable segment of the infection control market.
"Asia Pacific is expected to be the fastest-growing market for infection control during the forecast period, while North America leads in the market size"
The global infection control market is segmented into six segments, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific is the fastest-growing region in the infection control market, driven by its rapidly expanding healthcare infrastructure, rising patient volumes, and increasing awareness of infection prevention. The region is experiencing significant growth in hospital construction, medical tourism, and healthcare investments, which drives the demand for sterilization, disinfection, and hygiene solutions. The increasing occurrence of healthcare-associated infections, along with the implementation of stricter regulatory standards, is driving hospitals and clinics to adopt more advanced infection control practices. Furthermore, government initiatives, the growth of pharmaceutical and medical device manufacturing, and a large population base are contributing to the robust market growth in the region.
North America leads the infection control market due to its well-established healthcare system, advanced technological infrastructure, and high adoption rates of innovative infection prevention solutions. The region benefits from significant investments in healthcare research and development, stringent regulatory frameworks enforced by agencies like the FDA, and a strong presence of leading market players. Rising healthcare expenditures, a high prevalence of hospital-acquired infections, and a focus on patient safety further bolster demand for sterilization and disinfection products. Additionally, the region's mature market dynamics, supported by extensive training programs and awareness campaigns, ensure a steady uptake of cutting-edge technologies, solidifying North America's dominant position in the global infection control market.
Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the infection control market are STERIS (US), Reckitt Benckiser Group plc. (UK), Fortive (US), Sotera Health (US), and Solventum (US).
Research Coverage
This report examines the infection control market in terms of products & services, end-users, and regions. The report also examines key factors (including drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets in terms of their individual growth trends. It forecasts the revenue of the market segments with respect to six major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms and smaller entrants to gauge the market's pulse, which in turn will help them garner a larger market share. Firms purchasing the report could use one or more strategies mentioned below to strengthen their market presence.
Analysis of key Drivers (Rising prevalence of HAIs, increasing number of surgical procedures, Advancements in reprocessing technologies; Increasing emphasis on sterilization & disinfection of food; Advancements in sterilization equipment technology; Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals)
Restraints (Growing concerns about the safety of reprocessed instruments; Consequences associated with chemical disinfectant use; High cost of endoscopy reprocessing and limited reimbursements)
Opportunities (Increasing prevalence of medical devices and pharmaceutical companies in developing nations; Reintegration of ethylene oxide sterilization; Growing utilization of E-beam sterilization)
Challenges (Sterilization of advanced medical devices; Alternative methods for surface disinfection; Increasing adoption of single-use medical devices)
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the infection control market
Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the infection control market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the infection control market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players, such as STERIS (US), Reckitt Benckiser Group plc. (UK), Fortive (US), Sotera Health (US), and Solventum (US)